The "AD Scientific Index" analyses the academic work of scientists using the H-index, i10 index and number of citations, and provides results that can be used to evaluate the productivity and efficiency of individuals and institutions. In addition to ranking according to "total H-index" for individuals and institutions, you can also see the ranking and analyses according to "Scientists Last 6 years H-index" and Subject Rankings.
* Total H Index Rankings
Ranking Based
On Selection :26
melanoma
lung cancer
drug development
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
42
31
0.738
* Total H Index Rankings
Ranking Based
On Selection :27
Oncology
Immunology
AllergoOncology
Cancer Antibody Discovery and Immunotherapy
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
41
32
0.780
* Total H Index Rankings
Ranking Based
On Selection :28
oncology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
40
29
0.725
* Total H Index Rankings
Ranking Based
On Selection :29
Oncology
DNA Repair
Translational Science
Project Management
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
37
20
0.541
* Total H Index Rankings
Ranking Based
On Selection :30
oncology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
32
17
0.531
* Total H Index Rankings
Ranking Based
On Selection :31
Oncology
Functional Genomics
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
30
23
0.767
* Total H Index Rankings
Ranking Based
On Selection :32
Oncology
drug repurposing
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
30
21
0.700
* Total H Index Rankings
Ranking Based
On Selection :33
Oncology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
29
28
0.966
* Total H Index Rankings
Ranking Based
On Selection :34
Oesophageal cancer
gastric cancer
biomarkers
targets
personalised medicine
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
29
22
0.759
* Total H Index Rankings
Ranking Based
On Selection :35
oncology
immunology
animal models
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
29
9
0.310
* Total H Index Rankings
Ranking Based
On Selection :36
Magnetic Resonance Imaging
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
28
20
0.714
* Total H Index Rankings
Ranking Based
On Selection :37
surgery and oncology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
26
25
0.962
* Total H Index Rankings
Ranking Based
On Selection :38
HIV-associated Cancers
Kaposi sarcoma
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
26
25
0.962
* Total H Index Rankings
Ranking Based
On Selection :39
Gynaecological Cancer
Clinical Trials
Ovarian Cancer Cell Biology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
25
18
0.720
* Total H Index Rankings
Ranking Based
On Selection :40
Oncology Research & Development
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
25
17
0.680
* Total H Index Rankings
Ranking Based
On Selection :41
Molecular Imaging
Translational Medicine
Clinical Trials
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
25
14
0.560
* Total H Index Rankings
Ranking Based
On Selection :42
oncology
breast cancer
lung cancer
geriatric oncology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
24
22
0.917
* Total H Index Rankings
Ranking Based
On Selection :43
oncology
primary care
early diagnosis
diagnostic interval
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
25
20
0.800
* Total H Index Rankings
Ranking Based
On Selection :44
Urological Malignancies
Epigenetic regulation
RNA Informatics
Computational Biology
Biocuration
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
24
20
0.833
* Total H Index Rankings
Ranking Based
On Selection :45
oncology
experimental therapeutics
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
23
17
0.739
* Total H Index Rankings
Ranking Based
On Selection :46
Oncology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
22
22
1.000
* Total H Index Rankings
Ranking Based
On Selection :47
Oncology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
22
21
0.955
* Total H Index Rankings
Ranking Based
On Selection :48
Early Phase Clinical Trials and Prostate Cancer
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
22
16
0.727
* Total H Index Rankings
Ranking Based
On Selection :49
Oncology
Gene transcription
DNA damage and repair
Cancer drug discovery
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
21
18
0.857
* Total H Index Rankings
Ranking Based
On Selection :50
Medical Oncology
Clinical Pharmacology
Drug development
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
20
20
1.000
Sarah J Danson
University of Sheffield
Sheffield, United Kingdom
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
42
31
0.738
melanoma
lung cancer
drug development
Debra Josephs
King's College London
London, United Kingdom
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
41
32
0.780
Oncology
Immunology
AllergoOncology
Cancer Antibody Discovery and Immunotherapy
Sheela Rao
Royal Marsden Hospital
London, United Kingdom
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
40
29
0.725
Mandy Watson
University of Manchester
Manchester, United Kingdom
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
37
20
0.541
Oncology
DNA Repair
Translational Science
Project Management
Peter Mullen
University of Saint Andrews
St Andrews, United Kingdom
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
32
17
0.531
Euan Stronach
GlaxoSmithKline
Needham, United Kingdom
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
30
23
0.767
Oncology
Functional Genomics
Farhat Khanim
University of Birmingham
Birmingham, United Kingdom
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
30
21
0.700
Oncology
drug repurposing
Richard Turkington
Queen's University Belfast
Belfast, United Kingdom
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
29
28
0.966
Russell Petty
University of Dundee
Dundee, United Kingdom
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
29
22
0.759
Oesophageal cancer
gastric cancer
biomarkers
targets
personalised medicine
William Feeney
GlaxoSmithKline
Needham, United Kingdom
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
29
9
0.310
oncology
immunology
animal models
Alexandre Khrapitchev
University of Oxford
Oxford, United Kingdom
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
28
20
0.714
Magnetic Resonance Imaging
Hamid Bakshi
University of Ulster
Coleraine, United Kingdom
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
26
25
0.962
Ramya Ramaswami
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
26
25
0.962
HIV-associated Cancers
Kaposi sarcoma
Heidi Sowter
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
25
18
0.720
Gynaecological Cancer
Clinical Trials
Ovarian Cancer Cell Biology
Muhammad Al-Hajj
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
25
17
0.680
Oncology Research & Development
Azeem Saleem
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
25
14
0.560
Molecular Imaging
Translational Medicine
Clinical Trials
Nicolò Matteo Luca Battisti
Royal Marsden Hospital
London, United Kingdom
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
24
22
0.917
oncology
breast cancer
lung cancer
geriatric oncology
Sally Stapley
University of Exeter
Exeter, United Kingdom
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
25
20
0.800
oncology
primary care
early diagnosis
diagnostic interval
Sarah Burge
University of Cambridge
Cambridge, United Kingdom
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
24
20
0.833
Urological Malignancies
Epigenetic regulation
RNA Informatics
Computational Biology
Biocuration
Natalie Cook
University of Manchester
Manchester, United Kingdom
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
23
17
0.739
oncology
experimental therapeutics
Simon R Lord
University of Oxford
Oxford, United Kingdom
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
22
22
1.000
Chakravarthi Bvsk
GlaxoSmithKline
Needham, United Kingdom
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
22
21
0.955
Simon Pacey
University of Cambridge
Cambridge, United Kingdom
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
22
16
0.727
Early Phase Clinical Trials and Prostate Cancer
Manikandan Periyasamy
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
21
18
0.857
Oncology
Gene transcription
DNA damage and repair
Cancer drug discovery
Mark P Lythgoe
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
20
20
1.000
Medical Oncology
Clinical Pharmacology
Drug development